Bloomios Shareholder Update and Growth Strategy

0

Bloomios went public in April 2021. Bloomios was founded with the belief that affordable, high-quality hemp-derived products should be available to those in the United States who need them to improve their daily activities. We are determined to become the premier manufacturer of hemp-derived products, supporting the most recognized brands in the industry.

Bloomios manufactures, markets and distributes supplements and cosmetic products derived from American hemp through wholesale distribution channels, manufactured by its wholly owned subsidiary Bloomios Private Label. We provide services including custom formulation, brand development and order fulfillment to a wide variety of customers including large and small brands, chain stores, vape shops and distributors. We offer our private label and white label clients a wide range of custom formulations and manufacturing services with over 220 hemp products in 12 categories.

Bloomios’ recent financings and cash flow have enabled the Company to acquire new software and hardware to further improve our manufacturing capabilities and operational efficiency. Specifically, the company purchased a new infused gum machine, a new high output printer, additional packaging equipment, software systems and many other items. This expansion and automation is expected to allow the company to increase production to 3-5 times our current manufacturing capacity. We also continue to strengthen our management team and now have 70 full-time employees.

Bloomios estimates that in our first full year of operation we will reach approximately $ 9 million in gross income and probably at breakeven or have a small loss.

In addition, Bloomios focuses on the vertical integration of targeted brand acquisitions, which allows us to address the direct consumer market at large. Through the addition of brand acquisitions, organic development and channel partnerships, we intend to offer a full line of high quality consumer products. The Company is currently conducting due diligence on several acquisition targets.

The Bloomios management team is committed to continuing to execute our growth and acquisition strategy to increase long-term shareholder value by creating profitable income.

We value all of our shareholders. If you have any questions or concerns, please do not hesitate to contact us at: [email protected]

About Bloomios Inc.

Bloomios manufactures, markets and distributes supplements and cosmetic products derived from American hemp through wholesale distribution channels, through its wholly owned subsidiary Bloomios Private Label. The Company provides services including custom formulation, brand development and order fulfillment to a wide variety of customers including small and large brands, chain stores, vaping stores and distributors. To provide our private label and white label customers with extensive collections of customizable hemp products that include over 220 products in 12 categories in addition to custom formulation and manufacturing services. Bloomios is headquartered at Santa barbara, california with its operations in Daytona Beach, Florida. To learn more: https://www.bloomios.com

Safe Harbor Declaration:

The matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate”, “believe”, “estimate”, “May”, “intend”, “expect” and similar expressions identify such forward-looking statements. The actual results, performances or achievements could differ materially from those envisaged, expressed or implied by the forward-looking statements contained in this document. These forward-looking statements are based in large part on the Company’s expectations and are subject to a number of risks and uncertainties. These include, without limitation, the risks and uncertainties associated with: competitive and other factors affecting the Company and its operations, its markets, its products and the performance of its distributors, the impact on national economies and local resulting from terrorist actions and subsequent US actions; and other factors detailed in reports filed by the company.

Bloomios contact details:
Michel Colline, CEO
[email protected]
(805) 222-6330

SOURCE Bloomios, Inc.

Related links

www.bloomios.com


Source link

Share.

Comments are closed.